Bill
SB 875
State Medicaid program; making contracted entities ineligible for capitated contracts for failure to meet certain minimum expense requirement. Effective date. Emergency.
2025 Regular Session
Introduced by Paul Rosino and 1 co-sponsor
The bill bans selling medetomidine or xylazine to buyers under 21 and requires proof of institutional use, along with recordkeeping and penalties to fund substance abuse programs.
Vetoed 05/09/2025